| Literature DB >> 34055020 |
Yuehui Zhang1, Xiaozhu Guo2, Shuting Ma2, Haoyue Ma2, Hang Li2, Yi Wang2, Zhen Qin2, Xiaoke Wu1, Yaguang Han1, Yanhua Han1.
Abstract
Polycystic ovary syndrome (PCOS) is a frequent gynecological female endocrinopathy, characterized by chronic anovulation, hyperandrogenism, and insulin resistance (IR). Menstrual disorders are one of the main clinical manifestations of PCOS. Other symptoms include hirsutism and/acne. At present, the treatment of PCOS with irregular menstruation is mainly based on oral contraceptives, but there are some side effects and adverse reactions. In recent years, more and more attention has been paid to the complementary and alternative medicine (CAM), which has been widely used in clinical practice. Modern Western medicine is called "conventional medicine" or "orthodox medicine," and the complementary and alternative medicine is called "unconventional medicine" or "unorthodox medicine." CAM includes traditional medicine and folk therapy around the world. Around 65-80% of world health management business is classified into traditional medicine by the World Health Organization, which is used as alternative medicine in Western countries. In our country, Chinese medicine, acupuncture, and other therapies are commonly used due to their significant efficacy and higher safety. Therefore, this review aims to summarize and evaluate the mechanisms and the effect of current complementary replacement therapy in the treatment of menstrual disorders caused by PCOS, so as to provide guidance for the following basic and clinical research.Entities:
Year: 2021 PMID: 34055020 PMCID: PMC8149243 DOI: 10.1155/2021/6678398
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
The summary of randomized studies of Chinese medicinal treatment on PCOS menstrual disorders.
| Study ID | Design | Sample size (human) | Interventions | Treatment duration | Outcomes | Limitation |
|---|---|---|---|---|---|---|
| 26 | RCT | 100 | Treatment arm: the tanshinone capsules Control arm: no intervention | 12 weeks | Treatment arm: not mentioned Control arm: not mentioned | Small sample size |
| 33 | Controlled trial | 100 | Treatment arm: BBR Control arm: no intervention | 6 months | Treatment arm: effective rate, 48.3 % (22 of 50) Control arm: no changes | Not mentioned blindness Not mentioned placebo |
| 35 | RCT | 150 | Treatment arm: BBR Control arm: metformin Placebo: no intervention | 3 months | Treatment arm: effective rate, 48.6 % (18 of 37) Control arm: effective rate, 36.8 % (14 of 38) Placebo: effective rate, 20.6 % (7 of 37) | Small sample size |
| 40 | RCT | 15 | Treatment arm: cinnamon Placebo: no intervention | 3–6 months | Treatment arm: not mentioned Control arm: not mentioned | Small sample size |
| 41 | RCT | 66 | Treatment arm: cinnamon Placebo: no intervention | 12 weeks | Treatment arm: not mentioned Placebo: not mentioned | Small sample size |
| 42 | RCT | 15 | Treatment arm: cinnamon Placebo: no intervention | 8 weeks | Treatment arm: not mentioned Placebo: not mentioned | Small sample size |
| 46 | 58 | Treatment arm: Cangfu Daotan decoction Control arm: metformin | 6 months | Treatment arm: effective rate, 82.7% (24 of 29) Control arm: effective rate, 65.5% (19 of 29) | Not mentioned blindness Not mentioned placebo | |
| 47 | 68 | Treatment arm: clomiphene and Cangfu Daotan decoction Control arm: clomiphene | 6 months | Treatment arm: effective rate, 88.6 % (31 of 35) Control arm: effective rate, 84.8 % (28 of 33) | Not mentioned blindness Not mentioned placebo | |
| 49 | 60 | Treatment arm: Cangfu daotan decoction and Diane-35 Control arm: no intervention | 3 months | Treatment arm: effective rate, 81.6 % (49 of 60) Control arm: not mentioned | Not mentioned blindness Not mentioned placebo Not mentioned control group | |
| 52 | 66 | Treatment arm: Zigui decoction Control arm: Diane-35 | 3 months | Treatment arm: effective rate, 45.45 % (15 of 33) Control arm: effective rate, 21.21 % (7 of 33) | Not mentioned blindness Not mentioned placebo | |
| 53 | 40 | Treatment arm: standardized Chinese herbal medicine Control arm: no intervention | 6 months | Treatment arm: effective rate, 52.6 % (10 of 19) Control arm: not mentioned | Not mentioned blindness Not mentioned placebo Not mentioned control group | |
| 54 | 60 | Treatment arm: metformin, Dian-35 and danzhi xiaoyao pill Control arm: metformin and Dian-35 | 3 months | Treatment arm: effective rate, 87.5 % (21 of 24) Control arm: effective rate, 58.3 % (14 of 24) | Not mentioned blindness Not mentioned placebo | |
| 55 | 48 | Treatment arm: Longdan xiegan decoction Control arm: Diane-35 | 3 months | Treatment arm: effective rate, 82.6 % (19 of 23) Control arm: effective rate, 78.26 % (18 of 23) | Not mentioned blindness Not mentioned placebo | |
| 56 | 22 | Treatment arm: Tiangui decoction Control arm: metformin | 3 months | Treatment arm: effective rate, 60 % (6 of 10) Control arm: effective rate, 33.3 % (4 of 12) | Not mentioned blindness Not mentioned placebo |
Figure 1[81]. Human acupoint map GV24 Shengting, GV26 Shuigou, CV22 Tiantu, CV1 Zigong, CV17 Tanzhong, CV15 Jiuwei, CV12 Zhongwan, CV4 Guanyuan, CV2 Qvku, CV1 Huiyin, LU1 Zhongfu, KI24 Lingxu, LU3 Tianfu, LU6 Kongzui, PC8 Laogong, ST31 Biguan, CV3 Dahe, ST32 Futu, ST34 Liangqiu, ST35 Dubi, ST36 Zusanli, ST39 Xiajuxu, GB28 Weidao, SP13 Fushe, KI14 Siman, LR12 Qichong, LI15 Jianyu, GB23 Zhejin, SP21 Dabao, LI11 Quchi, LI16 Pianli, LI4 Hegu, GB30 Huantiao, GB31 Fengshi, GB34 Yanglingquan, SP9 Yinlingquan, SP8 Diji, SP6 Sanyinjiao, KI4 Dazhong, SP5 Shangqiu, SP3 Taibai, GV16 Fengfu, GV14 Dazhui, GV12 Shengzhu, GV11 Shendao, GV9 Zhiyang, BL18 Ganshu, GV7 Zhongshu, BL21 Weishu, GV4 Mingmen, GV3Yangguan, BL33Zhongliao, GV2 Yaoshu, GV1Changqiang, TE15 Tianliao, TE14 Jianliao, BL11 Dashu, BL13 Feishu, BL43Gaohuang, BL44 Shengtang, BL15 Xinshu, SI8 Xiaohai, TE9 Sidu, BL23 Shenshu, TE5 Waiguan, BL25 Dachangshu, BL28 Pangguangshu, BL54 Zhibian, BL37 Yinmen, BL40 Weizhong, BL57 Chengshan, and BL60 Kunlun.
The summary of randomized studies of acupuncture treatment on PCOS menstrual disorders.
| Study ID | Design | Sample size (human) | Interventions | Treatment duration | Outcomes | Limitation |
|---|---|---|---|---|---|---|
| 72 | RCT | 86 | Treatment arm: Abdominal acupuncture Control arm: metformin | 6 months | 1. HOMA-IR were reduced significantly in the two groups ( | Lack of sham methods |
| 74 | RCT | 342 | Treatment arm: true acupuncture + metformin placebo Control arm: sham acupuncture + metformin, sham acupuncture + metformin placebo | 4 months | Treatment arm: HOMA-IR decrease 25% Control arm: HOMA-IR decrease 5% | The limitation of being a single center study without comparison groups |
| 76 | RCT | 181 | Treatment arm: acupuncture group Control arm: same physical therapists | 10–13 weeks | Treatment arm: effective rate, 62.5% (10 of 16) Control arm: effective rate, 41.6% (5 of 12) | |
| 77 | RCT | 60 | Treatment arm: Tung's acupuncture group Control arm: CPA/EE group | 12 weeks | Treatment arm: LH/FSH ratio −0.66, | Clinical improvement of symptoms was not examined in this study |
| 78 | Nonrandomized, longitudinal, prospective study | 60 | Treatment arm: electro-acupuncture group Control arm: No intervention | 3 months | Treatment arm: effective rate, 37.5 % (9 of 24) Control arm: not mentioned | The sample size is small |
| 80 | RCT | 84 | Treatment arm: low-frequency electro-acupuncture Control arm: no intervention | 16 months | Treatment arm: effective rate, 72.9% (43 of 59) Control arm: effective rate, 33.3% (5 of 15) | Low success rate to confirm ovulation (data not shown) |
| 81 | RCT | 84 | Treatment arm: electro-acupuncture group; Physical exercise Control arm: no intervention | 32 weeks | Treatment arm: effective rate, 74.4% (32 of 43) Control arm: effective rate, 48.7% (20 of 41) | The sample size is small |
| 82 | RCT | 32 | Treatment arm: acupuncture group Control arm: attention control | 4 months | Treatment arm: effective rate, 68.75 % (11 of 16) Control arm: effective rate, 37.5 % (6 of 16) | |
| 88 | RCT | 143 | Treatment arm: true acupuncture Control arm: sham acupuncture | 5 months | Treatment arm: effective rate, 57.5% (23 of 40) Control arm: effective rate, 47.7 % (21 of 44) | |
| 109 | RCT | 70 | Treatment arm: heat-sensitive moxibustion plus clomifene citrate capsules Control arm: oral clomifene citrate capsules | 6 months | Treatment arm: effective rate, 51.5% (18 of 35) Control arm: effective rate, 20 % (7 of 35) | The sample size is small |
| 111 | RCT | 84 | Treatment arm: metformin and acupoint thread-embedding Control arm: oral metformin | 3 months | Treatment arm: effective rate, 87.5 % (35 of 40) Control arm: effective rate, 65.9 % (27 of 41) | The sample size is small |